CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,907,919 | -4.4% | 1,840,482 | -8.5% | 0.04% | -5.4% |
| Q2 2023 | $12,450,492 | +82.1% | 2,011,388 | +13.3% | 0.04% | +76.2% |
| Q1 2023 | $6,835,606 | +2666.7% | 1,775,482 | +2127.7% | 0.02% | +2000.0% |
| Q4 2022 | $247,070 | -47.9% | 79,700 | -32.3% | 0.00% | -50.0% |
| Q3 2022 | $474,000 | -27.2% | 117,800 | -11.8% | 0.00% | -33.3% |
| Q2 2022 | $651,000 | -92.0% | 133,600 | -85.3% | 0.00% | -90.6% |
| Q1 2022 | $8,136,000 | -34.2% | 907,000 | -17.4% | 0.03% | -34.7% |
| Q4 2021 | $12,362,000 | +144.9% | 1,097,908 | +263.3% | 0.05% | +122.7% |
| Q3 2021 | $5,047,000 | +127.2% | 302,200 | +202.2% | 0.02% | +120.0% |
| Q2 2021 | $2,221,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $89,357,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $179,070,000 | 48.51% |
| Vida Ventures Advisors, LLC | 3,931,818 | $35,268,000 | 20.51% |
| OUP Management Co., LLC | 2,937,615 | $26,350,000 | 20.06% |
| Samsara BioCapital, LLC | 1,884,096 | $16,900,000 | 4.26% |
| Kynam Capital Management, LP | 669,100 | $6,002,000 | 1.95% |
| Cormorant Asset Management, LP | 2,489,894 | $22,334,000 | 1.72% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $86,846,000 | 0.79% |
| RA Capital Management | 3,577,094 | $32,087,000 | 0.70% |
| BVF INC/IL | 1,755,545 | $15,747,000 | 0.63% |